Education
About Us
Working with TipRanks
Follow Us
Ayurcann Holdings Corp. (TSE:AYUR)
:AYUR
AYUR Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.05
Previous CloseN/A
Volume0.00
Average Volume (3M)59.98K
Market Cap
C$973.52K
Enterprise ValueC$550.67K
Total Cash (Recent Filing)C$1.09M
Total Debt (Recent Filing)C$667.58K
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding194,703,860
10 Day Avg. Volume17,939
30 Day Avg. Volume59,984
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)-1.65
Price to Sales (P/S)0.16
P/FCF Ratio2.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained TTM revenue growth of +55.3% indicates the company is expanding product adoption and market reach. Durable top-line momentum supports scale advantages, improves leverage on fixed costs, and provides a platform for margin recovery and long-term reinvestment if cost discipline follows.
Proprietary Extraction TechnologyOwnership of proprietary extraction and product development capabilities creates a structural competitive advantage: it enables differentiated SKUs, potential B2B ingredient sales, and higher technical barriers to entry. That supports sustained product innovation and distribution partnerships.
Relative Cash-generation AlignmentA free cash flow to net income ratio near 1 suggests reported losses still convert materially to cash, indicating some resilience in underlying cash generation. Combined with a moderate gross margin, this improves prospects for reaching cash break-even through scale and cost control over the medium term.
Bears Say
Negative Equity And Extreme LeverageNegative shareholders' equity and a debt-to-equity ratio of -7.77 signal severe balance-sheet stress and potential solvency risks. This structural leverage constrains financial flexibility, increases refinancing risk, and hampers the company’s ability to invest organically or pursue strategic opportunities.
Persistently Unprofitable OperationsNegative EBIT and a net margin of -12.5% show the business is not yet generating profits after operating costs. Persistent unprofitability erodes capital, limits reinvestment, and makes sustainable growth dependent on either significant margin improvement or recurrent external funding.
Deteriorating Free Cash FlowA 72.4% TTM decline in free cash flow and negative operating cash flow to net income indicate weakening cash conversion. This structural cash-generation deterioration raises reliance on external financing and heightens liquidity risk, limiting execution of growth plans without deleveraging.
Ayurcann Holdings Corp. News
AYUR FAQ
What was Ayurcann Holdings Corp.’s price range in the past 12 months?
Ayurcann Holdings Corp. lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
What is Ayurcann Holdings Corp.’s market cap?
Ayurcann Holdings Corp.’s market cap is C$973.52K.
When is Ayurcann Holdings Corp.’s upcoming earnings report date?
Ayurcann Holdings Corp.’s upcoming earnings report date is Mar 04, 2026 which is in 8 days.
How were Ayurcann Holdings Corp.’s earnings last quarter?
Currently, no data Available
Is Ayurcann Holdings Corp. overvalued?
According to Wall Street analysts Ayurcann Holdings Corp.’s price is currently Overvalued.
Does Ayurcann Holdings Corp. pay dividends?
Ayurcann Holdings Corp. does not currently pay dividends.
What is Ayurcann Holdings Corp.’s EPS estimate?
Ayurcann Holdings Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ayurcann Holdings Corp. have?
Ayurcann Holdings Corp. has 194,703,860 shares outstanding.
What happened to Ayurcann Holdings Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ayurcann Holdings Corp.?
Currently, no hedge funds are holding shares in TSE:AYUR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ayurcann Holdings Corp.
Ayurcann Holdings Corp. (AYUR) is a Canadian company specializing in the production and distribution of cannabis-derived products, focusing on innovative formulations that cater to both the medical and recreational markets. The company operates primarily in the cannabis sector, offering a range of products including oils, capsules, and edibles, with an emphasis on quality and sustainability. Ayurcann is committed to leveraging its proprietary extraction technology and product development capabilities to meet the evolving needs of consumers in the burgeoning cannabis industry.
Technical Analysis
Mountain Valley MD
―
Revive Therapeutics
―
PharmaCielo
―
Sweet Earth Holdings
―
Lobe Sciences
―